EGF and prostate cancer: Similar to the effect on 22Rv1 cells, treatment with AZA1 at 5 and 10 μM resulted in dramatically reduced filopodia formation in DU 145 prostate cancer cells after 24 h compared to EGF-stimulated cells (Figure S4B, upper three panels).